Kindeva Drug Delivery has announced a new agreement with Israeli medical cannabis company Breath of Life International (BOL Pharma) for development of formulations of several cannabinoids for delivery via Kindeva MDIs. The formulations will initially be for the purpose of feasibility studies. BOL intends to develop the MDIs for the treatment of CND conditions … [Read more...] about Kindeva to develop inhaled cannabinoid formulations for BOL Pharma
Products and Services
Kinaset to develop Vectura inhaled pan-JAK inhibitor for the treatment of asthma
US-based startup Kinaset Therapeutics has signed a licensing and develop an inhaled pan-JAK inhibitor that was in Vectura's pipeline prior to that company's transformation into an inhalation CDMO. In July 2019, Vectura announced that it intended to find partners for development of its inhaled drug candidates. The pan-Jak inhibitor, called VR588 by Vectura and now … [Read more...] about Kinaset to develop Vectura inhaled pan-JAK inhibitor for the treatment of asthma
Nanoform introduces nanoforming technology for biologics
Nanoform Finland has announced the launch of new nanonization technology that is capable of creating biological nanoparticles down to 50 nm. The company said that it has filed for US patents covering the technology and currently has two non-GMP lines capable of producing biological nanoparticles for a proof of concept study. Nanoform CTO Niklas Sandler said, "We … [Read more...] about Nanoform introduces nanoforming technology for biologics
MSP launches NGI+ cascade impactor
MSP, a division of TSI, has announced the launch of an enhanced Next Generation Impactor (NGI) called the NGI+, which is designed for improved resistance to corrosion and longer life expectancy. According to MSP, which was acquired by TSI in 2016, existing NGIs can also be upgraded to the new standard. The NGI+'s greater tolerance of harsh conditions makes the … [Read more...] about MSP launches NGI+ cascade impactor
Synairgen turns to Parexel for help with Phase 3 trial of inhaled interferon beta for COVID-19
Parexel announced that Synairgen has signed a collaboration agreement with Parexel Biotech for a Phase 3 trial of Synairgen's SNG001 nebulized interferon-beta-1a for the treatment of COVID-19. In July 2020, Synairgen announced positive results from a Phase 2 trial of SNG001 in COVID-19 patients hospitalized in the UK. The Phase 3 SG018 trial is expected to enroll 900 … [Read more...] about Synairgen turns to Parexel for help with Phase 3 trial of inhaled interferon beta for COVID-19
Monaghan Medical to move ahead with sales of Adherium’s Hailie inhaler monitoring system in US respiratory centers
Adherium has announced that Monaghan Medical is set to begin a pilot program to launch Adherium's Hailie inhaler monitoring platform in eight US respiratory centers by the end of the first quarter of 2021, with more centers expected to be added later in the year. The companies announced their partnership in April 2020 and now say that they have completed training and … [Read more...] about Monaghan Medical to move ahead with sales of Adherium’s Hailie inhaler monitoring system in US respiratory centers
Zeteo Biomedical to provide nasal delivery technology for Iowa State University vaccine against SARS-CoV-2
Zeteo Biomedical said that the company will supply its ZEOx2 nasal delivery system and unit dose packaging for use with a shelf-stable SARS-CoV-2 vaccine in development at the Nanovaccine Institute at Iowa State University. Zeteo is already working with Iowa State on an intranasal universal flu vaccine. The ZEOx2 platform can be used for intranasal delivery of dry … [Read more...] about Zeteo Biomedical to provide nasal delivery technology for Iowa State University vaccine against SARS-CoV-2
Kindeva Drug Delivery begins construction of new headquarters
CDMO Kindeva Drug Delivery announced that it has broken ground on a new 137,500 sq ft headquarters building in Woodbury, MN, USA; the company anticipates that the building will be opened in the latter half of 2021. Kindeva, formerly 3M Drug Delivery Systems, offers a wide range of services to support OINDP development and manufacturing, ranging from formulation to … [Read more...] about Kindeva Drug Delivery begins construction of new headquarters
Altimmune signs deal with Lonza for AdCOVID manufacturing
Altimmune has signed a manufacturing agreement with Lonza for its AdCOVID intranasal vaccine candidate for the prevention of COVID-19, the companies said. In March 2020, Altimmune announced that it had partnered with the University of Alabama Birmingham for development of AdCOVID; the company subsequently announced an agreement with DynPort Vaccine Company for funding … [Read more...] about Altimmune signs deal with Lonza for AdCOVID manufacturing
Aptar acquires Cohero Health
Aptar has announced its acquisition of Cohero Health and all of its assets, including Cohero's HeroTracker inhaler sensors, BreatheSmart app and platform, and mSpirometer sensors. Cohero Health CEO Joe Condurso will join Aptar Pharma. Since mid-2019, Aptar has acquired a number of OINDP companies, including connected device company Sonmol, training device maker Noble … [Read more...] about Aptar acquires Cohero Health